SUPN vs WAT · rev $426.8M vs P/E 32, rev $3.17B
Supernus Pharmaceuticals Inc (SUPN) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
SUPN currently screens at market cap $2.53B. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the SUPN and WAT stock pages for the full models.
Not investment advice.